✦ LIBER ✦

A New Approach to Modeling Covariate Effects and Individualization in Population Pharmacokinetics-Pharmacodynamics

✍ Scribed by Tze Leung Lai; Mei-Chiung Shih; Samuel P. Wong

Publisher: Springer
Year: 2006
Tongue: English
Weight: 335 KB
Volume: 33
Category: Article
ISSN: 1573-8744
DOI: 10.1007/s10928-005-9000-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Application of a system analysis approac

Application of a system analysis approach to population pharmacokinetics and pharmacodynamics of nicardipine hydrochloride in healthy males

✍ Nishit B. Modi; Peter Veng-Pedersen; Doug J. Graham; Rob J. Dow 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 848 KB

A New Exact Test for the Evaluation of P

A New Exact Test for the Evaluation of Population Pharmacokinetic and/or Pharmacodynamic Models Using Random Projections

✍ Celine Marielle Laffont; Didier Concordet 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 777 KB

A New Modeling Approach to the Effect of

A New Modeling Approach to the Effect of Antimicrobial Agents on Heterogeneous Microbial Populations

✍ Michael Nikolaou; Vincent H. Tam 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 406 KB

Pharmacokinetic-pharmacodynamic modellin

Pharmacokinetic-pharmacodynamic modelling of the cardiovascular effects of drugs – method development and application to magnesium in sheep

✍ Richard N Upton; Guy L Ludbrook 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 737 KB

## Background There have been few reports of pharmacokinetic models that have been linked to models of the cardiovascular system. Such models could predict the cardiovascular effects of a drug under a variety of circumstances. Limiting factors may be the lack of a suitably simple cardiovascular mod

Application of pharmacokinetic–pharmacod

Application of pharmacokinetic–pharmacodynamic modeling to predict the kinetic and dynamic effects of anti-methotrexate antibodies in mice

✍ Evelyn D. Lobo; David M. Soda; Joseph P. Balthasar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

We have shown that intravenous (i.v.) administration of anti-methotrexate (MTX) antibodies (AMAb) reduces the systemic exposure of intraperitoneal (i.p.) MTX therapy, and we have proposed that AMAb effects on MTX systemic exposure would allow a reduction in MTX-induced systemic toxicity (i.e., produ

A limited sampling method to estimate me

A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARM

✍ F. Bressolle; L. Edno; C. Bologna; J. Sany; J. C. Bernard; B. Combe; R. Gomeni 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 806 KB

This paper describes a methodology to calculate methotrexate (MTX) pharmacokinetic parameters after intramuscular administration using two samples and the population parameters. Total and free MTX were measured over a 36-h period in 56 rheumatoid arthritis patients; 14 patients were studied after a